---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-036060"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2024-09-12T23:59:59+00:00"
generated_at: "2026-05-31T05:22:38.078087+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech amends CEO/COO employment: CEO salary $650k plus $100k stock

## Summary
- CEO Equels: cash salary reduced to $650,000, plus $100,000 in restricted shares for one year ending Sept 11, 2025.
- COO Rodino: base salary $375,000 plus $50,000 in shares; period corrected to one year ending Aug 12, 2025.
- Amendment corrects prior duration error in August 2024 compensation changes for both officers.
- Shares valued at 100% of Sept 10, 2024 closing price; compensation committee approved the revisions.

## SEC filing metadata
- accession: 0001493152-24-036060
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2024-09-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 3.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315224036060/0001493152-24-036060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315224036060/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-036060
- JSON: https://secwatch.observer/filing/0001493152-24-036060.json
- Plain text: https://secwatch.observer/filing/0001493152-24-036060.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.